Citigroup’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.58M Buy
119,861
+119,233
+18,986% +$3.77M ﹤0.01% 2042
2025
Q4
$13.7K Sell
628
-679
-52% -$14.1K ﹤0.01% 4966
2025
Q3
$28.1K Sell
1,307
-3,970
-75% -$89K ﹤0.01% 4701
2025
Q2
$135K Sell
5,277
-2,572
-33% -$75.3K ﹤0.01% 4268
2025
Q1
$287K Sell
7,849
-922
-11% -$31.7K ﹤0.01% 3988
2024
Q4
$269K Buy
8,771
+13
+0.1% +$432 ﹤0.01% 4225
2024
Q3
$330K Buy
8,758
+5,943
+211% +$229K ﹤0.01% 4009
2024
Q2
$111K Buy
2,815
+559
+25% +$18.1K ﹤0.01% 4157
2024
Q1
$75.8K Buy
2,256
+287
+15% +$9.65K ﹤0.01% 4417
2023
Q4
$65.6K Buy
1,969
+1,916
+3,615% +$61.8K ﹤0.01% 4395
2023
Q3
$1.66K Sell
53
-5,756
-99% -$181K ﹤0.01% 5011
2023
Q2
$184K Buy
5,809
+5,475
+1,639% +$177K ﹤0.01% 3926
2023
Q1
$11K Sell
334
-141
-30% -$4.62K ﹤0.01% 4693
2022
Q4
$15.3K Sell
475
-230
-33% -$7.83K ﹤0.01% 4698
2022
Q3
$25K Sell
705
-484
-41% -$20.1K ﹤0.01% 4648
2022
Q2
$49K Buy
1,189
+274
+30% +$13.3K ﹤0.01% 4545
2022
Q1
$54K Sell
915
-2,321
-72% -$127K ﹤0.01% 4692
2021
Q4
$190K Buy
3,236
+1,727
+114% +$105K ﹤0.01% 4386
2021
Q3
$92K Buy
1,509
+513
+52% +$30.1K ﹤0.01% 4443
2021
Q2
$60K Sell
996
-94
-9% -$4.71K ﹤0.01% 4731
2021
Q1
$51K Sell
1,090
-1,373
-56% -$56.5K ﹤0.01% 4696
2020
Q4
$93K Buy
2,463
+1,498
+155% +$49.4K ﹤0.01% 5586
2020
Q3
$32K Sell
965
-13,779
-93% -$583K ﹤0.01% 5882
2020
Q2
$668K Buy
14,744
+10,929
+286% +$558K ﹤0.01% 3959
2020
Q1
$174K Buy
3,815
+1,237
+48% +$56K ﹤0.01% 4843
2019
Q4
$111K Buy
2,578
+1,252
+94% +$51K ﹤0.01% 5678
2019
Q3
$48K Sell
1,326
-1,260
-49% -$53.1K ﹤0.01% 6147
2019
Q2
$121K Buy
2,586
+233
+10% +$9.85K ﹤0.01% 5693
2019
Q1
$82K Sell
2,353
-127
-5% -$4.99K ﹤0.01% 5930
2018
Q4
$92K Sell
2,480
-98
-4% -$3.83K ﹤0.01% 5717
2018
Q3
$87K Buy
2,578
+2,190
+564% +$64.1K ﹤0.01% 6031
2018
Q2
$10K Sell
388
-603
-61% -$16.8K ﹤0.01% 7175
2018
Q1
$29K Buy
991
+773
+355% +$25.9K ﹤0.01% 6524
2017
Q4
$7K Buy
218
+182
+506% +$5.86K ﹤0.01% 7141
2017
Q3
$1K Sell
36
-63
-64% -$1.72K ﹤0.01% 7098
2017
Q2
$2K Sell
99
-236
-70% -$5.48K ﹤0.01% 6960
2017
Q1
$8K Sell
335
-5,930
-95% -$134K ﹤0.01% 6626
2016
Q4
$141K Buy
6,265
+5,420
+641% +$131K ﹤0.01% 5561
2016
Q3
$19K Sell
845
-184
-18% -$4.11K ﹤0.01% 6228
2016
Q2
$22K Sell
1,029
-9,676
-90% -$305K ﹤0.01% 6092
2016
Q1
$368K Buy
10,705
+10,704
+1,070,400% +$283K ﹤0.01% 4471
2015
Q4
$0 Sell
1
-16
-94% -$438 ﹤0.01% 7535
2015
Q3
$0 Sell
17
-596
-97% -$19.5K ﹤0.01% 7361
2015
Q2
$26K Buy
+613
New +$28.9K ﹤0.01% 5951

Other funds holding ATEX

Citigroup's ATEX Position: Q1 2026 in Review

Citigroup increased its Anterix (ATEX) stake by 18,986% in Q1 2026, buying an estimated $3.77M and bringing the position to 119,861 shares worth $4.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

Citigroup first reported a position in ATEX in Q2 2015 and has held it in 44 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Citigroup held 119,861 shares of Anterix worth $4.58M as of Q1 2026.
  • Citigroup bought 119,233 Anterix shares in Q1 2026, an estimated $3.77M.
  • Anterix made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2042 holding.
  • Citigroup first reported a position in Anterix in Q2 2015 and has held it in 44 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.